Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 4,268 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: ADM Clear all

Conditions: Stress Reaction, Stress, Emotional, Stress, COVID-19 Pandemic
Interventions: Questionnaires; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 415 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Osteosarcoma
Interventions: Ifosfamide, Carboplatin, Doxorubicin, Limb Sparing; Drug · Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 25 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1999 – 2006
U.S. locations: 3
States / cities: Little Rock, Arkansas • St Louis, Missouri • Memphis, Tennessee

Conditions: Orthopedic Trauma Surgery Patients, Postoperative Pain, Opioid Use, Depression, Post-traumatic Stress Disorder (PTSD)
Interventions: Ketamine, standard general anesthesia; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years to 65 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Lubbock, Texas

Conditions: Traumatic Brain Injury
Interventions: Constraint-Induced Movement Therapy (CIMT), Lakeshore Enriched Fitness Training (LEFT), standard Transfer Package (sTP), enhanced Transfer Package (eTP); Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 90 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stress Disorders, Post-Traumatic, Anxiety Disorders, Mental Disorder, Traumatic Disorder
Interventions: Prolonged Exposure; Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Urothelial Carcinoma, Bladder Cancer
Interventions: Abiraterone acetate, Durvalumab, Methotrexate, Vinblastine, Doxorubicin Hydrochloride, Cisplatin; Other · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 2
States / cities: Bloomington, Indiana • Houston, Texas

Conditions: Triple Negative Breast Cancer, Breast Neoplasms
Interventions: P10s-PADRE with MONTANIDE™ ISA 51 VG, Doxorubicin, Cyclophosphamide, Paclitaxel; Biological · Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older · Female only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Fayetteville, Arkansas • Little Rock, Arkansas

Conditions: Breast Cancer
Interventions: MR spectroscopy; Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Breast Neoplasms, Breast Cancer, Breast Tumors, Cancer of the Breast, Neoplasms, Breast, Tumors, Breast
Interventions: Eribulin, Doxorubicin, Cyclophosphamide, Pegfilgrastim; Drug
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 4
States / cities: Atlanta, Georgia • Madison, Wisconsin

Conditions: Surgery
Interventions: ECG; Device
Lead sponsor: Senthil G. Krishna; Other
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obesity
Interventions: Sugar reduction health education program, Control health education program, Home water delivery; Behavioral · Other
Lead sponsor: Children's Hospital Los Angeles; Other
Eligibility: 18 Years to 59 Years · Female only
Enrollment: 211 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hyperglycemia, Postoperative Infection
Interventions: Not listed
Lead sponsor: Boston Medical Center; Other
Eligibility: 18 Years to 89 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Auditory Processing Disorder
Interventions: Communication Counseling, Hearing Aids, Remote Microphones; Behavioral · Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 79 Years
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: No Condition
Interventions: Connection to community services through case management, TOGETHER Workshop, Employment Support Services; Behavioral
Lead sponsor: Virginia Polytechnic Institute and State University; Other
Eligibility: 18 Years and older
Enrollment: 584 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: College Park, Maryland • Gaithersburg, Maryland • Falls Church, Virginia

Conditions: Chronic Liver Disease
Interventions: EUS liver biopsy; Procedure
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: Not listed
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Opioid Use Disorder, Chronic Pain
Interventions: Steps 2 Change (S2C), Control; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: West Haven, Connecticut

Conditions: Lymphoma, B-Cell, Follicular Lymphoma
Interventions: Bortezomib, Rituximab, Doxorubicin, Cyclophosphamide, Vincristine, Prednisone; Drug · Biological
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Wellness, Self Compassion, Burnout, Anxiety, Depression
Interventions: App-based bundled mental fitness intervention, App-based wellness module collection; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Marijuana Use, Pregnancy
Interventions: eSBIRT, Tailored texting; Behavioral
Lead sponsor: Wayne State University; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Insomnia, Psychosis
Interventions: Cognitive Behavioral Therapy-Insomnia, Health and Wellness; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Agitation, Anesthesia, Pediatrics
Interventions: Dexmedetomidine, Saline; Drug
Lead sponsor: St. Luke's-Roosevelt Hospital Center; Other
Eligibility: 6 Months to 17 Years
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Non-Hodgkin's Lymphoma
Interventions: Doxorubicin, Rituxan, Cyclophosphamide, Vincristine and Prednisone; Drug
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Renal Cell Carcinoma
Interventions: HC-7366, Belzutifan; Drug
Lead sponsor: HiberCell, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 21
States / cities: Tucson, Arizona • La Jolla, California • Los Angeles, California + 15 more

Conditions: Sexually Transmitted Diseases
Interventions: Horizons+General Health Promotion (GHP), Horizons+Motivational Enhancement Therapy (GMET); Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 560 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Search by objective public record fields.

COVID-19 Pandemic Induced Stress and Symptoms

Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma

Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients

The Brave Initiative: Bringing Rehabilitation to American Veterans in an Enriched Environment

Peer Social Support During In Vivo Exposure for PTSD

A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder

Vaccination of Triple Negative Breast Cancer Patients

Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy

Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer

Effect of Dexmedetomidine on QT Interval in Pediatric Patients Under General Anesthesia

Improving the Eating Habits of Mother and Her Infant Via Sugar Reduction

Hyperglycemia in Neurosurgery

Hearing Aids for Veterans With Functional Hearing Difficulties

TOGETHER: A Couple's Model to Enhance Relationships and Economic Stability

Comparison and Outcomes of Endoscopic Ultrasound Liver Biopsies Versus Percutaneous Liver Biopsies

An Adaptive Walking Intervention to Manage Chronic Pain in Veterans With Opioid Use Disorder Engaged in Opioid Agonist Treatment

A Phase I/II Trial of VR-CHOP in Lymphoma Patients

A Study of a Mental Fitness Intervention for Anesthesiology Resident Wellbeing and Self-Compassion

Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Project N-Liten- HIV Prevention for African American Women